Aclaris Therapeutics (ACRS) announced that it has initiated a placebo-controlled Phase 1b proof-of-concept trial in atopic dermatitis for ATI-052, the company’s potential best-in-class investigational ...

WAYNE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...

WAYNE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...

AI isn't a single capability, and "using AI" isn't a strategy. The strategy is to know what we're building, why it matters ...

Recently published Atopic Dermatitis Market Insights report includes a comprehensive understanding of current treatment ...

Threading prior knowledge into new material makes for more durable learning. Here are 12 research-backed, teacher-tested strategies to help kids unpack what they already know.

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Eric's career includes extensive work in both public and corporate ...

Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.

Learn the benefits and risks of options and how to start trading options Lucas Downey is the co-founder of MoneyFlows, and an Investopedia Academy instructor. Samantha (Sam) Silberstein, CFP®, CSLP®, ...

Is innovation inherently a hit-or-miss endeavor? Not if you understand why customers make the choices they do. by Clayton M. Christensen, Taddy Hall, Karen Dillon and David S. Duncan For as long as we ...

Convincing runners to add strength training to their schedules is no easy feat. But hear us out: Lifting weights can make you a better runner in a few different ways. You’ll run more efficiently, ...